Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.76
-0.01-0.36%
At close: -
$2.76
0.000.00%
After Hours: Dec 20, 4:01 PM EDT
Comments
Loading...
CalciMedica (NASDAQ:CALC) Stock, Analyst Ratings, Price Targets, Forecasts
CalciMedica Inc has a consensus price target of $18 based on the ratings of 6 analysts. The high is $22 issued by JonesTrading on February 16, 2024. The low is $13 issued by LUCID CAPITAL MARKETS on December 17, 2024. The 3 most-recent analyst ratings were released by LUCID CAPITAL MARKETS, HC Wainwright & Co., and HC Wainwright & Co. on December 17, 2024, November 14, 2024, and November 4, 2024, respectively. With an average price target of $15 between LUCID CAPITAL MARKETS, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 443.48% upside for CalciMedica Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
LUCID CAPITAL MARKETS
HC Wainwright & Co.
Oppenheimer
HC Wainwright & Co.
JonesTrading
1calculated from analyst ratings
Analyst Ratings for CalciMedica
Data brought to you by Benzinga APIs
FAQ
What is the target price for CalciMedica (CALC) stock?
The latest price target for CalciMedica (NASDAQ:CALC) was reported by LUCID CAPITAL MARKETS on December 17, 2024. The analyst firm set a price target for $13.00 expecting CALC to rise to within 12 months (a possible 371.01% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CalciMedica (CALC)?
The latest analyst rating for CalciMedica (NASDAQ:CALC) was provided by LUCID CAPITAL MARKETS, and CalciMedica initiated their buy rating.
When was the last upgrade for CalciMedica (CALC)?
There is no last upgrade for CalciMedica
When was the last downgrade for CalciMedica (CALC)?
There is no last downgrade for CalciMedica.
When is the next analyst rating going to be posted or updated for CalciMedica (CALC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CalciMedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CalciMedica was filed on December 17, 2024 so you should expect the next rating to be made available sometime around December 17, 2025.
Is the Analyst Rating CalciMedica (CALC) correct?
While ratings are subjective and will change, the latest CalciMedica (CALC) rating was a initiated with a price target of $0.00 to $13.00. The current price CalciMedica (CALC) is trading at is $2.76, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.